REGENERON PHARMACEUTICALS, INC.

Manufacturing · Pharmaceutical Preparations

Disclosed trades

Correlations

Peak signal

48/100

SEC filings

EDGAR ↗

Share price · disclosed trades marked

purchase saleend-of-day close · markers placed on disclosed trade dates

Timing correlations · 1

Administration communication · 30 days after the trade

paired with Purchase on Mar 2, 2026

signal / 100

“Fact Sheet: President Donald J. Trump Announces Deal with Regeneron to Bring Most-Favored-Nation Pricing to American Patients – The White House”

Authority1.00

Corroboration0.00

Trade magnitude0.16

Entity specificity1.00

Temporal proximity0.12

Directional consistency0.50

Disclosed trades · 1

Date	Type	Amount range	Price at trade	Since trade
Mar 2, 2026	Purchase	$15,001 – $50,000	$781.67	-17.8%

“Since trade” is the EOD price change from the transaction date to the latest close — an indicative figure, not a realized return; disclosed amounts are ranges, so exact share counts are unknown.